BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30347681)

  • 1. Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells.
    Kutkowska J; Strzadala L; Rapak A
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non-small cell lung cancer cells.
    Kutkowska J; Strzadala L; Rapak A
    Cancer Sci; 2017 Nov; 108(11):2265-2272. PubMed ID: 28846180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia increases the apoptotic response to betulinic acid and betulin in human non-small cell lung cancer cells.
    Kutkowska J; Strzadala L; Rapak A
    Chem Biol Interact; 2021 Jan; 333():109320. PubMed ID: 33181113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib synergizes human pancreatic ductal adenocarcinoma cells to sorafenib-induced growth inhibition.
    Rosendahl AH; Gundewar C; Said K; Karnevi E; Andersson R
    Pancreatology; 2012; 12(3):219-26. PubMed ID: 22687377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of betulinic acid on proliferation, migration, cell cycle and apoptosis of pancreatic cancer cells].
    Jiang M; Zhou Y; Yang M; Zhang R; Zou M; Cai G; Pan D
    Zhongguo Zhong Yao Za Zhi; 2010 Nov; 35(22):3056-9. PubMed ID: 21355282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma.
    Wong MH; Xue A; Baxter RC; Pavlakis N; Smith RC
    Neoplasia; 2016 Jul; 18(7):425-35. PubMed ID: 27435925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma.
    Aboukameel A; Muqbil I; Senapedis W; Baloglu E; Landesman Y; Shacham S; Kauffman M; Philip PA; Mohammad RM; Azmi AS
    Mol Cancer Ther; 2017 Jan; 16(1):76-87. PubMed ID: 28062705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Cancer Inhibition by Betulinic Acid Nanoparticles via Adenosine 5'-Triphosphate (ATP)-Binding Cassette Transporter G1 Gene Downregulation.
    Zhao H; Mu X; Zhang X; You Q
    Med Sci Monit; 2020 Apr; 26():e922092. PubMed ID: 32277808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-O-(E)-p-Coumaroyl betulinic acid possess anticancer activity and inhibit Notch signaling pathway in breast cancer cells and mammosphere.
    Kushwaha PP; Singh AK; Shuaib M; Prajapati KS; Vardhan PS; Gupta S; Kumar S
    Chem Biol Interact; 2020 Sep; 328():109200. PubMed ID: 32702347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
    Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
    Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic Acid Affects the Energy-Related Proteomic Profiling in Pancreatic Ductal Adenocarcinoma Cells.
    Chiu CF; Chang HY; Huang CY; Mau CZ; Kuo TT; Lee HC; Huang SY
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer.
    Guo Y; Zhu H; Weng M; Wang C; Sun L
    BMC Complement Med Ther; 2020 Jun; 20(1):178. PubMed ID: 32513155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of betulinic acid on the regulation of Hiwi and cyclin B1 in human gastric adenocarcinoma AGS cells.
    Yang LJ; Chen Y; Ma Q; Fang J; He J; Cheng YQ; Wu QL
    Acta Pharmacol Sin; 2010 Jan; 31(1):66-72. PubMed ID: 20037601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.
    Awasthi N; Zhang C; Hinz S; Schwarz MA; Schwarz RE
    J Exp Clin Cancer Res; 2013 Mar; 32(1):12. PubMed ID: 23497499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K target based novel cyano derivative of betulinic acid induces its signalling inhibition by down-regulation of pGSK3β and cyclin D1 and potentially checks cancer cell proliferation.
    Majeed R; Hussain A; Sangwan PL; Chinthakindi PK; Khan I; Sharma PR; Koul S; Saxena AK; Hamid A
    Mol Carcinog; 2016 May; 55(5):964-76. PubMed ID: 26013878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cell cycle arrest and apoptosis by betulinic acid-rich fraction from Dillenia suffruticosa root in MCF-7 cells involved p53/p21 and mitochondrial signalling pathway.
    Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; How CW; Armania N; Loh SP; Ismail IS; Cheah YK; Abdullah R
    J Ethnopharmacol; 2015 May; 166():270-8. PubMed ID: 25797115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling.
    Sun L; Cao J; Chen K; Cheng L; Zhou C; Yan B; Qian W; Li J; Duan W; Ma J; Qi D; Wu E; Wang Z; Liu Q; Ma Q; Xu Q
    Int J Oncol; 2019 Jan; 54(1):98-110. PubMed ID: 30365057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
    Hsu TI; Wang MC; Chen SY; Huang ST; Yeh YM; Su WC; Chang WC; Hung JJ
    Mol Pharmacol; 2012 Dec; 82(6):1115-28. PubMed ID: 22956772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers.
    Cohen SM; Mukerji R; Timmermann BN; Samadi AK; Cohen MS
    Am J Surg; 2012 Dec; 204(6):895-900; discussion 900-1. PubMed ID: 23231932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.